Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Asimadoline hydrochloride (EMD-61753 hydrochloride) 是一种 κ-阿片(κ-opioid)受体激动剂,对豚鼠和人重组 κ-opioid 的 IC50值分别为 5.6 和 1.2 nM。它可改善糖尿病大鼠的异常性疼痛,具有外周抗炎作用,并有用于肠易激综合征的研究潜力。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 329 | 现货 | ||
2 mg | ¥ 477 | 现货 | ||
5 mg | ¥ 723 | 现货 | ||
10 mg | ¥ 1,160 | 现货 | ||
25 mg | ¥ 2,320 | 现货 | ||
50 mg | ¥ 3,450 | 现货 | ||
100 mg | ¥ 4,890 | 现货 | ||
500 mg | ¥ 9,870 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 837 | 现货 |
产品描述 | Asimadoline hydrochloride (EMD-61753 hydrochloride) is a κ-opioid receptor agonist potentially for the treatment of pruritus. Asimadoline hydrochloride has also been shown to be used in the treatment of irritable bowel syndrome. |
靶点活性 | κ opioid (human recombinant):1.2 nM (EC50), κ opioid (Guinea pig):5.6 nM (EC50) |
体外活性 | The IC50 for Asimadoline binding to μ-opioid receptors is 3 μM and to δ-opioid receptors is 0.7 μM. At high concentrations, Asimadoline demonstrates spasmolytic action against 400 μM barium chloride in the rat duodenum (IC50: 4.2 μM), suggesting that Asimadoline may block the direct stimulant effects of barium on smooth muscle through mechanisms that are not identified[1]. |
体内活性 | The metabolism of Asimadoline is rapid and appears similar in animals and man. The absorption rate following oral administration is 80% in rats and >90% in dogs and monkeys. Asimadoline has peripheral anti-inflammatory actions that are partly mediated through an increase in joint fluid substance P levels[1]. Treatment with Asimadoline (5 mg/kg/day i.p.) produces marked (and sustained) attenuation of the disease with all three-time regimes[2]. |
动物实验 | Asimadoline (5 mg/kg/day, n=10 per group) or vehicle (2 mL/kg/day, n=10) is administered to DA rats by i.p. injection twice daily (i) during the primary inflammatory phase (days 1–3); (ii) once the disease is established (days 13–21); or (iii) throughout the entire time course (days 1-21). Non-arthritic control animals receive Asimadoline (5 mg/kg/day, n=5) or vehicle (2 mL/kg/day, n=5) by i.p. injection twice daily. In all cases, disease parameters are assessed. In this experiment, the SP content of joint tissue is assessed only after the rats are killed (day 21)[2]. |
别名 | EMD-61753 hydrochloride, 阿西马朵林盐酸盐 |
分子量 | 451.01 |
分子式 | C27H31ClN2O2 |
CAS No. | 185951-07-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 60 mg/mL (133.03 mM), Heating is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.2172 mL | 11.0862 mL | 22.1725 mL | 55.4311 mL |
5 mM | 0.4434 mL | 2.2172 mL | 4.4345 mL | 11.0862 mL | |
10 mM | 0.2217 mL | 1.1086 mL | 2.2172 mL | 5.5431 mL | |
20 mM | 0.1109 mL | 0.5543 mL | 1.1086 mL | 2.7716 mL | |
50 mM | 0.0443 mL | 0.2217 mL | 0.4434 mL | 1.1086 mL | |
100 mM | 0.0222 mL | 0.1109 mL | 0.2217 mL | 0.5543 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Asimadoline hydrochloride 185951-07-9 Endocrinology/Hormones GPCR/G Protein Neuroscience Opioid Receptor syndrome bowel diabetic EMD61753 EMD-61753 hydrochloride Asimadoline irritable κ-opioid δ-opioid EMD 61753 inhibit EMD61753 Hydrochloride Asimadoline Hydrochloride EMD-61753 EMD-61753 Hydrochloride μ-opioid allodynia EMD 61753 Hydrochloride Inhibitor 阿西马朵林盐酸盐 inhibitor